Search

everythinglearnresearchcommunity

for

Search:↓

Your lifestyle and health can affect your chances of getting COVID-19; not enough sleep, lots of exercise, and hair loss can increase risk, while washing hands, eating fruit daily, and taking vitamins A and C can lower it.

Hispanic women with PCOS are more likely to have liver diseases like NAFLD and NASH.

Iron deficiency in menstruating women causes many health issues beyond anemia and needs early detection and treatment.

Skin cancer is common in elderly nursing home residents, with risk factors including being male, having light skin, outdoor work history, and smoking. Regular skin checks are recommended.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

EtG in hair can help detect alcohol use but may be inaccurate in people with certain health conditions.

Vitiligo is underreported in medical claims and is linked to certain skin types and autoimmune diseases.

Certain genetic variations in the RAB5B gene are linked to a higher risk of polycystic ovary syndrome in Chinese Han women.

Lower SMAD2/3 activation predicts more severe skin cancer.

An alternating inflatable head pad reduced pressure ulcers and hair loss in heart surgery patients.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Girls with PCOS have higher levels of certain androgens, which are linked to excess hair growth, but these androgens don't help diagnose PCOS.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Ischemic modified albumin could be a new indicator of oxidative stress in people with alopecia areata.

One in four people still had symptoms like weight loss, hair loss, and fatigue 12-14 weeks after recovering from COVID-19.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

Finasteride use is not clearly linked to an increased risk of male breast cancer.

Stress can trigger or worsen alopecia areata.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

The study suggests pandemic stress might worsen or trigger hair loss problems.

Both concentrations of triamcinolone acetonide are effective for hair regrowth in patchy alopecia areata, but 5 mg/mL is recommended to reduce side effects.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

A model using hormone levels, cycle length, and BMI can help identify PCOS in Chinese women but isn't for screening teens.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Depression in women with Polycystic Ovarian Syndrome (PCOS) is linked to insulin resistance and hyperandrogenism, and managing these can help reduce depression. Lifestyle changes and Cognitive Behavioral Therapy can be effective treatments.

Eyelid cells share signaling components but differ in pathway activity.

Cow placenta extract has strong antioxidant effects and can delay skin aging in mice.

Too much epidermal growth factor can cause hair loss.

Androgenetic alopecia significantly affects quality of life, especially for women, who are more willing to pay for treatment.